The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 09, 2018

Filed:

Mar. 14, 2013
Applicant:

Biothera, Inc., Eagan, MN (US);

Inventors:

William J. Grossman, Third Lake, IL (US);

Mary A. Antonysamy, Woodbury, MN (US);

Richard M. Walsh, Lino Lakes, MN (US);

Mariana I. Nelson, Rosemount, MN (US);

Nandita Bose, Plymouth, MN (US);

Michael E. Danielson, St. Paul, MN (US);

Kyle S. Michel, Eagan, MN (US);

Assignee:

Biothera, Inc., Eagan, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 1/00 (2006.01); A61K 39/00 (2006.01); A61K 39/40 (2006.01); A61K 39/395 (2006.01); A61K 31/716 (2006.01); C07K 16/12 (2006.01); C07K 16/14 (2006.01); A61K 45/06 (2006.01); A61K 39/39 (2006.01); G01N 33/569 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 39/39583 (2013.01); A61K 31/716 (2013.01); A61K 39/39 (2013.01); A61K 39/39558 (2013.01); A61K 39/39575 (2013.01); A61K 45/06 (2013.01); A61K 47/6835 (2017.08); C07K 16/12 (2013.01); C07K 16/14 (2013.01); G01N 33/56966 (2013.01); A61K 2039/55583 (2013.01); G01N 2400/24 (2013.01);
Abstract

This disclosure describes, in one aspect, a composition that includes a β-glucan component and an antibody component that specifically binds to the β-glucan. In another aspect, this disclosure describes a method of increasing a subject's response to β-glucan immunotherapy. Generally, the method includes identifying the subject as a low binder of β-glucan and administering to the subject a composition that comprises a β-glucan moiety conjugated to the therapeutic antibody. In some cases, the therapeutic antibody can be an anti-tumor antibody.


Find Patent Forward Citations

Loading…